相关实验视频

Updated: May 8, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

清代的机制通过抑制JAK2/STAT3信号通路来缓解急性肺损伤

Lu Qi^1,2,3, Shun Wang^1,3, Tao Guo^1,3

¹The Research Center for Traditional Chinese Medicine, Shanghai Institute of Infectious Diseases and Biosecurity, Shanghai University of Traditional Chinese Medicine, Shanghai, 201203, People's Republic of China.

Journal of inflammation research

|December 26, 2024

概括

青 (QD) 通过抑制JAK2/STAT3途径有效治疗急性肺损伤 (ALI),为ALI和急性呼吸困扰综合征 (ARDS) 提供了潜在的新疗法. 这是一种传统的中医药.

科学领域:

药理学药理学是指药理学的学科.
传统中国医药传统中国医药
免疫学免疫学免疫学

背景情况:

青台 (QD) 是一种用于急性肺损伤/急性呼吸困扰综合征 (ALI/ARDS) 的中国传统医学 (TCM).
在ALI中,QD治疗效果的确切机制尚未完全理解.
调查QD的抗炎作用和分子点对于其临床应用至关重要.

研究的目的:

阐明青 (QD) 在脂聚糖 (LPS) 诱导的急性肺损伤 (ALI) 中发挥治疗作用的机制.
确定关键的分子标和信号通路,参与QD的抗炎作用.
评估QD作为ALI/ARDS治疗策略的潜力.

主要方法:

通过UPLC-LTQ-Orbitrap-MS/MS进行化合物识别.
网络药理学用于目标和途径预测.
分子对接以评估结合亲和力.
转录基因分析,HE染色,ELISA,RT-qPCR和西部斑点体内和体外模型.

主要成果:

确定了六个主要的QD组件;网络药理学和转录组学突出了JAK/STAT信号通路.
分子对接揭示了特定QD化合物的高结合亲和力与JAK2和STAT3.
在体内和体外的QD治疗显著降低了肺炎,并抑制了JAK2/STAT3信号通路.

结论:

青 (QD) 缓解了小鼠的LPS诱导的ALI.
QD的抗炎作用是通过抑制JAK2/STAT3信号通路进行介导的.
QD显示出作为ALI/ARDS的有价值的治疗剂的潜力.

关键词:

JAK2/STAT3 3 的情况.清代清代清代是一个肺部急性肺损伤是什么这是一种抗炎症药物.巨细胞是什么?巨细胞是什么?

更多相关视频

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

Amplifying Signals via Enzymatic Cascade

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...